The largest database of trusted experimental protocols

3 protocols using jnk2 sirna

1

Insulin Signaling in 3T3-L1 Adipocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse 3T3-L1 preadipocytes were obtained from American Type Culture Collection (Manassas, VA). 3T3-L1 preadipocyte medium, 3T3-L1 adipocyte differentiation medium, and 3T3-L1 adipocyte maintenance medium were obtained from Zen-Bio, Inc. (Research Triangle Park, NC). [1, 2-3H] 2-deoxy-D-glucose was purchased from Perkin Elmer Life Sciences (Waltham, MA). Hypochlorous sodium solution, human insulin, Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME), SP600125, and antibody against phospho-IRS-1 (Tyr612) were purchased from Sigma-Aldrich (St. Louis, MO). Protein A/G-agarose, RIPA lysis buffer, PS-1145, IKKβ siRNA, JNK2 siRNA, PKCθ siRNA, control siRNA, and antibodies against β-actin, GAPDH and Na+/K+ ATPase were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibodies against phospho-IRS-1 (Ser307), IRS-1, phospho-Akt (Ser473), phospho-Akt (Thr308), Akt, phospho-GSK3β (Ser9), GSK3β, phospho-IKKα/β (Ser176/180), IKKα, IKKβ, phospho-SAPK/JNK (Thr183/Tyr185), JNK, phospho-PKCθ (Thr538), PKCθ, GLUT4, IκBα, and horseradish peroxidase-linked secondary antibodies (Beverly, MA). ONOO was obtained from Calbiochem (Billerica, MA). All other chemicals were of the highest commercial grade available.
+ Open protocol
+ Expand
2

Modulation of TACE Activation by PKCβ

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were maintained in DMEM with 10% FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin. For drug treatments, 90% confluent cells were serum-starved for 4 h and then treated with 0.5 μm PMA (Sigma) or SP600125 (Merck Millipore, Billerica, MA). A PKCβ-selective inhibitor (539654, Merck Millipore), anisomycin (Sigma), and TAPI-0 (Merck Millipore) were used for 30 min before drug treatment. Cycloheximide, α-amanitin, and actinomycin D were purchased from Sigma. For overexpression or knockdown of specific proteins, transfection of cDNA or siRNA was performed. When cells reached 30%–40% confluence, cells were transfected with JNK1 siRNA, JNK2 siRNA, PKCα siRNA, PKCβ siRNA, and TACE siRNA (Santa Cruz Biotechnology, Dallas, TX), WT PKCβII cDNA, DN PKCβI (K371R), and DN PKCβII (K371R) cDNA (Addgene, Cambridge, MA) using Lipofectamine 2000 (Invitrogen) for 48–72 h. Control siRNA (catalog no. sc-37007, Santa Cruz Biotechnology), designed not to target any gene, was used as a negative control in knockdown experiments.
+ Open protocol
+ Expand
3

Insulin Resistance in 3T3-L1 Adipocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse 3T3-L1 preadipocytes were obtained from American Type Culture Collection (Manassas, VA, USA). 3T3-L1 preadipocyte medium, 3T3-L1 adipocyte differentiation medium, and 3T3-L1 adipocyte maintenance medium were obtained from Zen-Bio, Inc. (Research Triangle Park, NC, USA). [1,2-3H] 2-deoxy-d-glucose was purchased from Perkin Elmer Life Sciences (Waltham, MA, USA). Hypochlorous sodium solution, human insulin, Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME), SP600125, and antibody against phospho-IRS1 (Tyr612) were purchased from Sigma–Aldrich. Protein A/G-agarose, RIPA lysis buffer, PS-1145, IKKβ siRNA, JNK2 siRNA, PKCθ siRNA, control siRNA, and antibodies against β-actin, GAPDH, and Na+/K+ ATPase were obtained from Santa Cruz Biotechnology, Inc. Antibodies against phospho-IRS1 (Ser307), IRS1, phospho-Akt (Ser473), phospho-Akt (Thr308), Akt, phospho-GSK3β (Ser9), GSK3β, phospho-IKKα/β (Ser176/180), IKKα, IKKβ, phospho-SAPK/JNK (Thr183/Tyr185), JNK, phospho-PKCθ (Thr538), PKCθ, GLUT4, IκBα, and HRP-linked secondary antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). ONOO was obtained from Calbiochem (Billerica, MA, USA). All other chemicals were of the highest commercial grade available.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!